Work

Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome

Year: 2013

Type: article

Source: Cancer Cell

DOI: 10.1016/j.ccr.2013.05.006

Authors: Garrett W. Rhyasen, Lyndsey Bolanos, Jing Fang, Andres Jerez, Mark Wunderlich, Carmela Rigolino, Lesley Mathews, Marc Ferrer, Noel Southall, Rajarshi Guha, Jonathan Keller, Craig Thomas, Levi J. Beverly, Agostino Cortelezzi, Esther N. Oliva, Maria Cuzzola, Jaroslaw P. Maciejewski, James C. Mulloy, Daniel T. Starczynowski

Institutions: Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cleveland Clinic, Azienda ospedaliera "Bianchi-Melacrino-Morelli", National Institutes of Health, National Human Genome Research Institute, University of Louisville, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G1260873166, G3649799342, Identification and characterization of genes in del(5q) myelodysplastic syndrome

OpenAlex ID: W2018317651

FWCI: 11.25

Cites: 46

Cited by: 200

Related to: 10